This is not a documented risk of standard clinical practice with approved formulations and appropriate dosing
American Journal of Physiology-Cell Physiology
In these cases, the back pain is often worse and more troublesome
instillation of BPC 157 keeps vessel presentation constant and inhibits these stomach, esophagus, and duodenum lesions, whereas standard agents (atropine, ranitidine, omeprazole) only partially improve vessels and lesions
Because it degrades in blood in a pathway involving amino-peptidases, it may not be suitable for people who take medications that inhibit or are metabolized by peptidases (e.g., captopril, a treatment for hypertension).4 Also, based on what we know about other therapeutic peptides, we would say DSIP is contraindicated for women who are pregnant or breastfeeding as well as people with a personal history of cancer
Lancet 359 , 407408 (2002)